ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 103

$455K Total Retail Price of All Prescriptions

Rank: 41 out of 103

539 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 539 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 539 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,077 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
FUROSEMIDE 553 490 1 4
LEVOTHYROXINE SODIUM 550 488 2 1
SIMVASTATIN 479 405 3 2
LISINOPRIL 477 388 4 5
OMEPRAZOLE 445 324 5 3
WARFARIN SODIUM 350 349 6 7
AMLODIPINE BESYLATE 331 295 7 6
POTASSIUM CHLORIDE 278 241 8 10
DIGOXIN 270 269 9 25
METOPROLOL TARTRATE 268 255 10 9
ATENOLOL 266 222 11 14
METOPROLOL SUCCINATE 255 201 12 8
HYDROCODONE-ACETAMINOPHEN 171 118 S3 13 11
TRAMADOL HCL 153 133 14 17
METFORMIN HCL 145 73 15 13
ALLOPURINOL 142 138 16 26
POLYETHYLENE GLYCOL 3350 126 85 17 31
ATORVASTATIN CALCIUM 122 105 18 18
CITALOPRAM HBR 121 110 19 15
HYDROCHLOROTHIAZIDE 120 106 20 16
TAMSULOSIN HCL 117 107 21 23
ZOLPIDEM TARTRATE 100 80 22 29
ALENDRONATE SODIUM 98 95 23 19
ISOSORBIDE MONONITRATE ER 94 94 24 37
MIRTAZAPINE 93 68 25 36
CLONIDINE HCL 88 80 26 82
NEXIUM 86 73 27 43
PREDNISONE 85 79 28 24
GLYBURIDE 85 57 R 28 76
PRAVASTATIN SODIUM 84 70 30 33
KLOR-CON 10 79 67 31 45
GLIMEPIRIDE 77 41 32 50
LANTUS 75 55 33 39
LOSARTAN POTASSIUM 75 69 33 12
FENTANYL 73 60 S2 35 34
CEPHALEXIN 70 62 36 72
CRESTOR 70 56 36 27
FINASTERIDE 69 69 38 69
CLOPIDOGREL 69 66 38 32
VERAPAMIL ER 66 62 40 91
CARVEDILOL 66 56 40 20
GLIPIZIDE XL 63 39 42 120
RANITIDINE HCL 61 52 43 53
AZITHROMYCIN 61 59 43 44
GLIPIZIDE 61 49 43 65
LOSARTAN-HYDROCHLOROTHIAZIDE 60 44 46 47
INSULIN SYRINGE 60 48 46 75
NITROGLYCERIN PATCH 60 48 46 89
SPIRONOLACTONE 59 59 49 30
FENOFIBRATE 58 44 50 58
NOVOLOG 58 58 50 94
CARBIDOPA-LEVODOPA 58 58 50 55
ENALAPRIL MALEATE 55 44 53 63
ADVAIR DISKUS 53 33 54 42
IPRATROPIUM BROMIDE 52 52 55 128
NITROSTAT 52 48 55 157
KLOR-CON M20 51 51 57 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.